Company | Timeline | Status | |
Glaxosmithkline Intellectual Property (No.5) Limited Director • Vp R&d Finance, Respiratory & Immunology | 4 Apr 2024←1 Year 5 Months→Current | Liquidation | |
Glaxosmithkline Intellectual Property (No.4) Limited Director • Vp R&d Finance, Respiratory & Immunology | 4 Apr 2024←1 Year 5 Months→Current | Active | |
Glaxosmithkline Intellectual Property (No.3) Limited Director • Vp R&d Finance, Respiratory & Immunology | 4 Apr 2024←1 Year 5 Months→Current | Active | |
Glaxosmithkline Intellectual Property Holdings Limited Director • Vp R&d Finance, Respiratory & Immunology | 4 Apr 2024←1 Year 5 Months→Current | Active | |
Glaxosmithkline Intellectual Property (No.2) Limited Director • Vp R&d Finance, Respiratory & Immunology | 4 Apr 2024←1 Year 5 Months→Current | Active | |
Glaxosmithkline Intellectual Property Development Limited Director • Vp R&d Finance, Respiratory & Immunology | 4 Apr 2024←1 Year 5 Months→Current | Active | |
Glaxosmithkline Intellectual Property Limited Director • Vp R&d Finance, Respiratory & Immunology | 4 Apr 2024←1 Year 5 Months→Current | Active | |
Glaxosmithkline Intellectual Property Management Limited Director • Vp R&d Finance, Respiratory & Immunology | 4 Apr 2024←1 Year 5 Months→Current | Active | |
Glaxo Wellcome UK Limited Director • Vp R&d Finance, Respiratory & Immunology | 4 Apr 2024←1 Year 5 Months→Current | Active | |
Glaxosmithkline Intellectual Property (No.5) Limited Director • Vp R&d Finance, Respiratory & Immunology | 4 Apr 2024←12 Months→31 Mar 2025 | Liquidation |